期刊文献+

奎硫平与利培酮对血清催乳素影响对照研究 被引量:4

下载PDF
导出
摘要 目的:探讨奎硫平与利培酮对女性患者血清催乳素(PRL)及体质量指数(BMI)的影响。方法:将60例精神分裂症或分裂样精神病女性患者随机分为奎硫平组和利培酮组,每组各30例,采用磁酶免疫法测定两组治疗前后的PRL水平,并计算治疗前后体质量指数。结果:治疗后利培酮组PRL显著高于治疗前PRL(t=6.165,P<0.01)。治疗后利培酮组BMI和奎硫平组BMI均显著高于治疗前(P均<0.05),利培酮组高于奎硫平组(t=3.013,P<0.01)。结论:奎硫平对PRL影响不明显,利培酮对PRL影响明显。
出处 《临床精神医学杂志》 2009年第1期57-58,共2页 Journal of Clinical Psychiatry
  • 相关文献

参考文献7

  • 1齐红伟,盛树立.泌乳素,见:盛树立.多肽激素的当代理论和应用[M].北京:科学技术出版社,1998,121:129.
  • 2张向阳,周东丰,沈渔邨,张培琰,管振全,成秀芳,李道,南振国,白京生,石夏明,陈建,张艳平,李尚明.利培酮对慢性精神分裂症泌乳素的影响[J].中国神经精神疾病杂志,1999,25(2):93-94. 被引量:25
  • 3Seeman P. Atypical antipsychotics : mechanism of action[ J ]. Cau J Psychiatry, 2002,47 : 2738.
  • 4彭代辉,白艳乐,江开达.奎硫平与氯丙嗪对血清催乳素的影响[J].临床精神医学杂志,2005,15(4):212-213. 被引量:20
  • 5王克强,关恒永,蒋龙,耿寒松,李秋霞,刘占茹,李喜波,潘艳芬,谢宝钦.阿立哌唑与利培酮对血清催乳素水平的影响[J].临床精神医学杂志,2007,17(3):154-156. 被引量:28
  • 6Van Putten T,Marder SR, Marder SR, et al. Serum prolaction as a correlate of clinical response to haloperedol[ J ]. J Clin Psychopharmarol, 1991,11 : 357.
  • 7Matsui-Sakata. Rcceptor occupancy-based analysis of the contributions of various receptons to antipsychtics - induced Weight and diabetes mellitus [ J ] J Drug Metab Pharmacokinet, 2005,20 : 368- 378.

二级参考文献16

  • 1吴仁容,李乐华.新型抗精神病药:阿立哌唑[J].国外医学(精神病学分册),2004,31(3):177-179. 被引量:380
  • 2文斌,李文华,章秋明,曹青.阿立哌唑与利培酮治疗精神分裂症对照研究[J].临床精神医学杂志,2006,16(1):49-50. 被引量:74
  • 3DiSamo A,Landi ML,Marzullo P,et al.The effect of quinagolide and cabergoline,two selective dopamine receptor type2 agonists,in the treatment of prolactinomas[J].Clin Endocrinol(Oxf),2000,53:534.
  • 4Nordstrom AL,Farde L.Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patients[J].J Clin Psychopharmacol,1998,18:305.
  • 5Montero A,Bottasso OA,Luraghi MR,et al.Association between high serum prolactin levels and concomitant infections in HIV-infected patients[J].Hun Immunol,2001,62:191-196.
  • 6Yu Lee,Li Y.Molecular actions of prolactin in the immune system[J].Proc Soc Exp Biol Med,1997,215:35-52.
  • 7Chikanza IC.Prolactin and neuroimmunomodulation:in vitro and in vivo observations[J].Ann NY Acad Sci,1999,876:119-130.
  • 8Laughren TP,Brown WA,Williams BW.Serum prolactin and clinical state during neuroleptic treatment and withdrawal[J].Am J Psychiatry,1979,136:108-110.
  • 9Seeman P.Atypical antipsychotics:mechanism of action[J].Can J Psychiatry,2002,47:27-38.
  • 10Gold MS,Redmond DE,Donabedian RK,et al.Increase in serum prolactin by exogenous and endogenous opiates:evidence for antidopamine and antipsychotic effect[J].Am J Psychiatry,1978,135:1415-1416.

共引文献68

同被引文献35

  • 1汪春运.齐哌西酮的精神科应用[J].国外医学(精神病学分册),2005,32(1):40-43. 被引量:90
  • 2黄继忠,张明园.非典型抗精神病药治疗精神分裂症的临床应用评价[J].中国医院用药评价与分析,2005,5(2):75-80. 被引量:58
  • 3吉中孚.多巴胺受体部分激动剂的临床应用评价[J].中国医院用药评价与分析,2005,5(2):89-91. 被引量:35
  • 4Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain : a comprehensive research synthesis [ J ]. Amer J Psychiatry, 1999,156 : 1686.
  • 5Glassman AH. Clinical management of cardiovascular risks during treatment with psychotropic drugs[ J]. J Clin Psychiatry,2002,63: 12-17.
  • 6Wirshing DA, Pierre JM, Erhart SM, et al. Understanding the new and evolving profile of adverse drug effects in schizophrenia [ J ]. Psychiat Clin North Am,2003,26:165-190.
  • 7Lawer CP. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin reeeptorsubtypes [J]. Neuropsychopharmacology, 1999,20 (6) : 612-627.
  • 8Saha AR,Carson WH , Ali MW, et al. Efficacy and safety of aripiprazole and risperidone vs placebo in patients with schizo- phrenia and schizoaffective disorder [J]. Biol Psychiat, 2001,2 (Suppl) : 305-308.
  • 9江开达.精神药理学[M]{H}北京:人民卫生出版社,2011362-386.
  • 10黄雄,杜文佳,薛仕健,童梓顺,蒋泽宇.阿立哌唑与利培酮治疗精神分裂症的临床疗效及对血清催乳素的影响[J].药物不良反应杂志,2008,10(2):77-80. 被引量:18

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部